DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Information Disclosure Statement
The information disclosure statement (IDS) was filed on 01/09/2026. The submission is in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement is being considered by the examiner.
Drawings
The drawings are objected to as failing to comply with 37 CFR 1.84(p)(5) because they do not include the following reference sign(s) mentioned in the description: “Insulation joints 118” (Paragraph [0054]), “injection device 114” (Paragraph [0055]), and “nozzles 116” (Paragraph [0055]). Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance.
The drawings are objected to as failing to comply with 37 CFR 1.84(p)(5) because they include the following reference character(s) not mentioned in the description: “16” and “18” (Figure 4; different from reference characters “16” and “18” in Figure 3, which are mentioned in the description). Corrected drawing sheets in compliance with 37 CFR 1.121(d), or amendment to the specification to add the reference character(s) in the description in compliance with 37 CFR 1.121(b) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance.
Specification
The disclosure is objected to because of the following informalities:
“the’ 286 patent” in Paragraph [0004], Line 7 should read “the ‘286 patent”.
“each other, and the limit the chance” in Paragraph [0053], Lines 2-3 should read “each other and limit the chance”.
“wherein the gas turbine the diesel engine” in Paragraph [0060], Lines 1-2 should read “wherein the gas turbine or the diesel engine”.
Appropriate correction is required.
Double Patenting
A rejection based on double patenting of the “same invention” type finds its support in the language of 35 U.S.C. 101 which states that “whoever invents or discovers any new and useful process... may obtain a patent therefor...” (Emphasis added). Thus, the term “same invention,” in this context, means an invention drawn to identical subject matter. See Miller v. Eagle Mfg. Co., 151 U.S. 186 (1894); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Ockert, 245 F.2d 467, 114 USPQ 330 (CCPA 1957).
A statutory type (35 U.S.C. 101) double patenting rejection can be overcome by canceling or amending the claims that are directed to the same invention so they are no longer coextensive in scope. The filing of a terminal disclaimer cannot overcome a double patenting rejection based upon 35 U.S.C. 101.
Claims 1-20 are provisionally rejected under 35 U.S.C. 101 as claiming the same invention as that of claims 1-20 of copending Application No. 19/743,850 (reference application). This is a provisional statutory double patenting rejection since the claims directed to the same invention have not in fact been patented.
Allowable Subject Matter
Claims 1-20 would be allowable if rewritten or amended to overcome the statutory double patenting rejection(s) set forth in this Office action. The following is a statement of reasons for the indication of allowable subject matter: The prior art fails to disclose an injection system for cooling gas turbines or a diesel engine, the injection system comprising a first pump adapted to pressurize a liquid passing therethrough; a heat exchanger in fluid communication with said first pump, said heat exchanger adapted to elevate a temperature of the liquid from said first pump, said heat exchanger being connected to a source of heat; a second pump in fluid communication with said heat exchanger and downstream therefrom, said second pump adapted to increase the pressure of the liquid from said heat exchanger; an injection device downstream of said second pump, said injection device having a plurality of nozzles adapted to spray the liquid into an inflow duct of the gas turbine or diesel engine; a flow control valve downstream of said second pump and upstream of said injection device, said flow control valve adapted to limit a volume of the liquid flowing to said injection device; and an ionizer downstream of said flow control valve and upstream of said injection device, said ionizer adapted to impart a negative charge to the liquid such that the negatively-charged liquid is sprayed outwardly of the plurality of nozzles of said injection device. Pal (US Publication No: 2021/0352832) discloses a thermal management system for a gas turbine engine, the system comprising a first pump (Figure 1, No. 114), a heat exchanger (116), and a second pump (124); however, Pal fails to disclose an injection device having a plurality of nozzles, a flow control valve, or an ionizer downstream of said flow control valve and upstream of said injection device. Jones (US Patent No: 10,704,467) discloses a thermal management system for a gas turbine, the system comprising a first pump (Figure 2, No. 130), a heat exchanger (50) in fluid communication with said first pump (via lines 60 and 150), and a second pump (240) in fluid communication with said heat exchanger (via collector 220); however, Jones also fails to disclose an injection device having a plurality of nozzles, a flow control valve, or an ionizer downstream of said flow control valve and upstream of said injection device. Klosinski (US Patent No: 9,964,035) discloses a coolant injection system for a gas turbine, the system comprising a heat exchanger (Figure 1, No. 122), flow control valves (154), and an injection device (144) comprising a plurality of nozzles (Column 6, Lines 11-12); however, Klosinski fails to disclose first and second pumps or an ionizer downstream of said flow control valve and upstream of said injection device. The prior art fails to disclose an injection or cooling system as claimed; therefore, Claims 1-20 contain allowable subject matter.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL L SEHN whose telephone number is (571)270-3564. The examiner can normally be reached M-F 8:30 AM-6 PM, every other Friday off.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Courtney Heinle can be reached at 571-270-3508. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/MICHAEL L SEHN/Primary Examiner, Art Unit 3745